Concepedia

Class Effect Safety Analysis

Class Effect Safety Analysis is a systematic pharmacovigilance methodology that evaluates the shared safety profiles of drugs within the same therapeutic class to identify whether adverse effects are attributable to the entire class (class effects) rather than individual agents, thereby distinguishing class-wide risks from agent-specific risks in comparative drug safety assessment.

1

Publications

113

Citations

14

Authors

2

Institutions

Publications per year

2017–2026

0

Parents

Publications

1

1–2 of 1

Authors

14

  1. SX
    Shuting Xia

    Ionis Pharmaceuticals (United States), United States

    1 publications · 113 citations

    1

    h-index

  2. HB
    Huynh‐Hoa Bui

    La Jolla Institute for Immunology, United States

    1 publications · 113 citations

    1

    h-index

  3. SA
    Sebastien A. Burel

    Ionis Pharmaceuticals (United States), United States

    1 publications · 113 citations

    1

    h-index

  4. RS
    Richard S. Geary

    Ionis Pharmaceuticals (United States), United States

    1 publications · 113 citations

    1

    h-index

  5. CE
    Christopher E. Hart

    Ionis Pharmaceuticals (United States), United States

    1 publications · 113 citations

    1

    h-index

1–5 of 14

Institutions

2

  1. NGM Biopharmaceuticals (United States)

    South San Francisco, United States

    1 h-index

    1 publications

    113 citations

  2. Ionis Pharmaceuticals (United States)

    Carlsbad, United States

    1 h-index

    14 publications

    1.6K citations

  3. Kitasato University

    Tokyo, Japan

    1 publications

    17 citations

  4. Otsuka (Japan)

    Tokyo, Japan

    1 publications

    17 citations

1–4 of 2

Venues

  1. Molecular Therapy

    1 publications · 113 citations

    1

    h-index

  2. Journal of Clinical Pharmacy and Therapeutics

    1 publications · 17 citations

1–2